BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28871303)

  • 1. Polymeric mannosides prevent DC-SIGN-mediated cell-infection by cytomegalovirus.
    Brument S; Cheneau C; Brissonnet Y; Deniaud D; Halary F; Gouin SG
    Org Biomol Chem; 2017 Sep; 15(36):7660-7671. PubMed ID: 28871303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.
    Sutkeviciute I; Thépaut M; Sattin S; Berzi A; McGeagh J; Grudinin S; Weiser J; Le Roy A; Reina JJ; Rojo J; Clerici M; Bernardi A; Ebel C; Fieschi F
    ACS Chem Biol; 2014 Jun; 9(6):1377-85. PubMed ID: 24749535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Valent Calix[4]arene Glycoconjugates Based on Hydroxamic Acid Bearing Linkers as Potent Inhibitors in a Model of Ebola Virus Cis-Infection and HCMV-gB-Recombinant Glycoprotein Interaction with MDDC Cells by Blocking DC-SIGN.
    Chakroun K; Taouai M; Porkolab V; Luczkowiak J; Sommer R; Cheneau C; Mathiron D; Ben Maaouia MA; Pilard S; Abidi R; Mullié C; Fieschi F; Cragg PJ; Halary F; Delgado R; Benazza M
    J Med Chem; 2021 Oct; 64(19):14332-14343. PubMed ID: 34524803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine Mapping the Interaction Between Dendritic Cell-Specific Intercellular Adhesion Molecule (ICAM)-3-Grabbing Nonintegrin and the Cytomegalovirus Envelope Glycoprotein B.
    Chéneau C; Coulon F; Porkolab V; Fieschi F; Laurant S; Razanajaona-Doll D; Pin JJ; Borst EM; Messerle M; Bressollette-Bodin C; Halary F
    J Infect Dis; 2018 Jul; 218(3):490-503. PubMed ID: 29648611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation.
    Sattin S; Daghetti A; Thépaut M; Berzi A; Sánchez-Navarro M; Tabarani G; Rojo J; Fieschi F; Clerici M; Bernardi A
    ACS Chem Biol; 2010 Mar; 5(3):301-12. PubMed ID: 20085340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells.
    Martínez-Avila O; Bedoya LM; Marradi M; Clavel C; Alcamí J; Penadés S
    Chembiochem; 2009 Jul; 10(11):1806-9. PubMed ID: 19565596
    [No Abstract]   [Full Text] [Related]  

  • 7. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.
    Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
    Martínez-Avila O; Hijazi K; Marradi M; Clavel C; Campion C; Kelly C; Penadés S
    Chemistry; 2009 Sep; 15(38):9874-88. PubMed ID: 19681073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction.
    Taouai M; Porkolab V; Chakroun K; Cheneau C; Luczkowiak J; Abidi R; Lesur D; Cragg PJ; Halary F; Delgado R; Fieschi F; Benazza M
    Bioconjug Chem; 2019 Apr; 30(4):1114-1126. PubMed ID: 30912645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
    Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
    Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-carbohydrate inhibitors of the lectin DC-SIGN.
    Borrok MJ; Kiessling LL
    J Am Chem Soc; 2007 Oct; 129(42):12780-5. PubMed ID: 17902657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic micelles of mannoside glycolipids are more efficient than polymers for inhibiting HIV-1 trans-infection.
    Schaeffer E; Dehuyser L; Sigwalt D; Flacher V; Bernacchi S; Chaloin O; Remy JS; Mueller CG; Baati R; Wagner A
    Bioconjug Chem; 2013 Nov; 24(11):1813-23. PubMed ID: 24134734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile access to pseudo-thio-1,2-dimannoside, a new glycomimetic DC-SIGN antagonist.
    Tamburrini A; Achilli S; Vasile F; Sattin S; Vivès C; Colombo C; Fieschi F; Bernardi A
    Bioorg Med Chem; 2017 Oct; 25(19):5142-5147. PubMed ID: 28389114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
    Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
    J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assay for functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) inhibitors of human dendritic cell adhesion.
    Obermajer N; Svajger U; Jeras M; Sattin S; Bernardi A; Anderluh M
    Anal Biochem; 2010 Nov; 406(2):222-9. PubMed ID: 20667443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection.
    Halary F; Amara A; Lortat-Jacob H; Messerle M; Delaunay T; Houlès C; Fieschi F; Arenzana-Seisdedos F; Moreau JF; Déchanet-Merville J
    Immunity; 2002 Nov; 17(5):653-64. PubMed ID: 12433371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation.
    Mezger M; Steffens M; Semmler C; Arlt EM; Zimmer M; Kristjanson GI; Wienker TF; Toliat MR; Kessler T; Einsele H; Loeffler J
    Clin Microbiol Infect; 2008 Mar; 14(3):228-34. PubMed ID: 18076668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of DC-SIGN in DC-induced T cell proliferation.
    Gijzen K; Tacken PJ; Zimmerman A; Joosten B; de Vries IJ; Figdor CG; Torensma R
    J Leukoc Biol; 2007 Mar; 81(3):729-40. PubMed ID: 17135574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.
    Prost LR; Grim JC; Tonelli M; Kiessling LL
    ACS Chem Biol; 2012 Sep; 7(9):1603-8. PubMed ID: 22747463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DC-SIGN antagonists, a potential new class of anti-infectives.
    Anderluh M; Jug G; Svajger U; Obermajer N
    Curr Med Chem; 2012; 19(7):992-1007. PubMed ID: 22257062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.